Inderjeet Dokal

ORCID: 0000-0003-4462-4782 · 3 papers in corpus
review 2022
The biology and management of dyskeratosis congenita and related disorders of telomeres
·doi:10.1080/17474086.2022.2108784

BACKGROUND: Dyskeratosis congenita (DC) is a multisystem syndrome characterized by mucocutaneous abnormalities, bone marrow failure, and predisposition to cancer. Studies over the last 25 years have led to the identification of 18 disease g…

article 2016
In-vitro analysis of the effects of TA65 and danazol on the proliferation and telomerase activity of T lymphocytes in bone marrow failure syndromes
·doi:10.1016/s0140-6736(16)00416-5
letter 2013
Haematological recovery in dyskeratosis congenita patients treated with danazol
·doi:10.1111/bjh.12432

Dyskeratosis Congenita (DC) is a multi-system disorder of telomere biology in which bone marrow (BM) failure is the main cause of mortality (Savage & Bertuch, 2010; Mason & Bessler, 2011). The disease spectrum has expanded considerably sinc…